Humana Inc. (NYSE:HUM) is a prominent player in the health insurance industry, providing a range of health, wellness, and insurance services. The company competes with other major insurers like UnitedHealth Group and Anthem. On February 2, 2026, Morgan Stanley downgraded Humana to an "Underweight" rating from "Equal Weight," with the stock priced at $195.20 at the time.
Despite the downgrade, Tejara Capital Ltd has shown confidence in Humana by acquiring 7,200 shares valued at approximately $1.87 million, as reported in their latest 13F filing with the SEC. This move aligns with other hedge funds like Elevation Point Wealth Partners LLC and Mather Group LLC, which have also initiated new positions in Humana, valued at around $32,000 and $34,000, respectively.
Private Wealth Management Group LLC has increased its holdings in Humana by 47.5% during the third quarter, now owning 149 shares valued at $39,000. This indicates a growing interest among investors, despite the recent downgrade by Morgan Stanley. The stock is currently priced at $195.20, reflecting a slight decrease of 0.75% or $1.47.
The stock has experienced fluctuations, with a daily low of $192.40 and a high of $197.34. Over the past year, Humana's stock has seen a high of $315.35 and a low of $191.39. The company's market capitalization stands at approximately $23.48 billion, with a trading volume of 3,220,371 shares on the NYSE.
